VS Peps
← Back to Tesamorelin

VS Peps · Certificate № JN-260530-2025

Certificate of Analysis

Compound identity

TSM

Tesamorelin

Stabilized GHRH analog · 10mg lyophilized

Batch identifiers

Batch IDJN-260530-2025
Lab referenceLR-34425
Test date2026-05-30
Format10mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

99.2%

Area under the target peak as a percentage of total area.

Batch · 2026-05-30Janoshik Analytical · HPLC
99.2%TSM2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameTesamorelin
Editorial codeTSM
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

44residues
3-letter notation

44-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.

Modifications

  • 01N-terminal trans-3-hexenoyl group for stabilization

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 14 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-30

Document control

Certificate № JN-260530-2025Issued 2026-05-30Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.